We were founded to conduct research for the people, by the people and provide data freely to the public for psychedelic education and guidance. Our parent nonprofit, Realm of Caring, has informed 22 states as they worked to legalize cannabis. We’re doing the same for psychedelics.
Our psilocybin study conducted in 2020, is still the largest in the world, with over 8000 participants. Our first publication (of many) from the study has more views than 99% of all published articles.
In partnership with leading institutions such as Johns Hopkins, UCSF, Imperial College London, MIT and Harvard, our research goes beyond the clinical lab to reflect how psychedelics are actually used in everyday life. By analyzing outcomes from lived experience, we’re shaping education, informing public policy, supporting harm reduction and meeting the evolving needs of communities seeking healing through natural medicine.
Interested in conducting a study? Reach out to our team.
Over the years, we’ve heard countless ideas for thoughtful and important research. Every project takes real funding, real visibility and real engagement to come to life. That’s why we’re creating the research roadmap: to give voice (and credit!) to your ideas as they shape the future of psychedelic science.
The roadmap will showcase what matters to our community, helping to prioritize funding opportunities. Additionally, we often get questions from Info Line callers that we can’t answer with research. We see that feedback as a call-to-action. As we build out the online roadmap, you can upvote ideas or submit your own to co-create what comes next.
Visit the roadmap to upvote ideas like these:
Do mushrooms make people more loving and compassionate?
Does psilocybin reconnect humans to earth and each other?
Do psychedelics reduce burnout, improve mental health or resilience at work?
If you integrate with like-minded people / groups, is your integration more successful?
What is psilocybin’s effect on healing from abusive relationships?
How can we measure the impact of preparation on psychedelic outcomes?
Do magic mushroom experiences make you a better parent?
Despite much progress in psychedelic research, the field lacks standardized terminology to guide clinical development, dosing, safety monitoring, and regulatory classification. Here, we present a comprehensive framework for psychedelic nomenclature based on pharmacology, subjective effects, dosing, and therapeutic use.
After non-clinical psilocybin consumption, we observed increases in mind perception across a variety of living and non-living targets (like plants and rocks). However, we found little to no change in metaphysical beliefs or Atheist-Believer status.
This longitudinal study gathered data on ceremonial ayahuasca use in a group of Middle Eastern and North African (MENA) immigrants and refugees. Our findings revealed ceremonial use of ayahuasca is associated with significant improvements in mental health, well-being and psychological functioning.
This study of naturalistic psilocybin usage found significant differences in persisting psilocybin effects in the domains of spiritual wellbeing, cognitive flexibility, and expressive suppression for White participants vs. Participants of Color.
We collect data from people using psychedelics in the real world, in therapeutic, ceremonial and private settings. Unlike lab-based trials, analyzing outcomes from lived experience delivers practical data for community support, product development, investment direction and policy change.
Our suite of naturalistic research services is fully customizable:
Interested in our research services? Reach out to our team.
With 35+ published papers and 125+ years of combined experience, our research team leads the industry in real-world studies that move the needle.
We work with clients in:
